Influence of endogenous oestrogens on QT interval duration

European Heart Journal

Volumn 24, Issue 18, 2003, Pages 1663-1667

  Hulot, Jean Sébastien ^a   Démolis, Jean Louis ^a   Rivière, Rachel ^a   Strabach, Soraya ^a   Christin Maitre, Sophie ^a   Funck Brentano, Christian ^a  

^a HÔPITAL SAINT ANTOINE   (France)

Author keywords

Electrocardiology; Long QT syndrome; Sex hormones; Torsades de pointes

Indexed keywords

ESTRADIOL; ESTROGEN;

ADULT; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE ASSOCIATION; EXERCISE TEST; FEMALE; HEART RATE; HEART REPOLARIZATION; HORMONE ACTION; HORMONE BLOOD LEVEL; HUMAN; MENSTRUAL CYCLE; MENSTRUATION; OVULATION; PRIORITY JOURNAL; QT INTERVAL; R WAVE; TORSADE DES POINTES;

ADOLESCENT; ADULT; ELECTROCARDIOGRAPHY; ESTRADIOL; FEMALE; HEART CONDUCTION SYSTEM; HEART RATE; HUMANS; MENSTRUAL CYCLE; SEX FACTORS; VENTRICULAR FUNCTION;

EID: 0141538222     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0195-668X(03)00436-6     Document Type: Conference Paper

References (19)

1. Lehmann MH, Hardy S, Archibald D et al. Sex difference in risk of torsade de pointes with d,l-sotalol. Circulation 1996;94:2535-41.
2. Drici MD, Knollmann BC, Wang WX et al. Cardiac actions of erythromycin: influence of female sex. JAMA 1998;280:1774-6.
3. Démolis JL, Charransol A, Funck-Brentano C et al. Effects of a single oral dose of sparfloxacin on ventricular repolarization in healthy volunteers. Br J Clin Pharmacol 1996;41:499-503.
4. Démolis JL, Kubitza D, Tennezé L et al. Effect of a single oral dose of moxifloxacin (400 mg and 800 mg) on ventricular repolarization in healthy subjects. Clin Pharmacol Ther 2000;68:658-66.
5. Makkar RR, Fromm BS, Steinman RT et al. Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs. JAMA 1993;270:2590-7.
6. Benton RE, Sale M, Flockhart DA et al. Greater quinidine-induced QTc interval prolongation in women. Clin Pharmacol Ther 2000;67:413-8.
7. Rodriguez I, Kilborn MJ, Liu X et al. Drug-induced QT prolongation in women during the menstrual cycle. JAMA 2001;285:1322-6.
8. Bazett HC. An analysis of the time-relations of electrocardiograms. Heart 1920;7:353-70.
9. Rautaharju PM, Zhou SH, Wong S et al. Sex differences in the evolution of the electrocardiographic QT interval with age. Can J Cardiol 1992;8:690-5.
10. Drici MD, Burklow TR, Haridasse V et al. Sex hormones prolong the QT interval and downregulate potassium channel expression in the rabbit heart. Circulation 1996;94:1471-4.
11. Ebert SN, Liu XK, Woosley RL. Female gender as a risk factor for drug-induced cardiac arrhythmias: evaluation of clinical and experimental evidence. J Womens Health. 1998;7:547-57.
12. Lu HR, Marien R, Saels A et al. Are there sex-specific differences in ventricular repolarization or in drug-induced early after depolarizations in isolated rabbit purkinje fibers? J Cardiovasc Pharmacol 2000;36:132-9.
13. Funck-Brentano C, Jaillon P. Rate-corrected QT interval: techniques and limitations. Am J Cardiol 1993;72:17B-22B.
14. Lepeschkin E, Surawicz B. The measurement of the Q-T interval of the electrocardiogram. Circulation 1952;6:378-88.
15. Funck-Brentano C, Kibleur Y, Le Coz F et al. Rate dependence of sotalol-induced prolongation of ventricular repolarization during exercise in humans. Circulation 1991;83:536-45.
16. Stramba-Badiale M, Locati EH, Martinelli A et al. Gender and the relationship between ventricular repolarization and cardiac cycle length during 24-h Holter recordings. Eur Heart J 1997;18:1000-6.
17. Burke JH, Ehlert FA, Kruse JT et al. Gender-specific differences in the QT interval and the effect of autonomic tone and menstrual cycle in healthy adults. Am J Cardiol 1997;79:178-81.
18. Goldsien A. Ovaries. In: Greenspan F, Gardner D, editors. Basic and Clinical Endocrinology, 6th edn. New York: Lange Medical Book/McGraw-Hill; 2001, p. 453-508.
19. Larsen JA, Tung RH, Sadananda R et al. Effects of hormone replacement therapy on QT interval. Am J Cardiol 1998;82:993-5.